Mastermind Discussion: Personalized VS Non-Personalized Dosimetry in Widespread RLT Treatment – Necessary or Unsustainable?

• Comparing personalized versus standard dosimetry approaches and their impact on patient safety and treatment efficacy
• Assessing operational, logistical, and cost challenges of implementing individualized dosimetry at scale
• Evaluating strategies to balance precision treatment with practical feasibility in widespread RLT adoption

Speakers:

Jessica Guarnaschelli

Independent Consultant

CURADH Pharmaceuticals